SCHOTT Pharma AG & Co. KGaA Cash Flow Quality Index
SCHOTT Pharma AG & Co. KGaA cash flow quality index. SCHOTT Pharma AG & Co. KGaA (1SXP) has a Cash Flow Quality Index of 2.24x as of September 2024. Operating cash flow of €75.97 Million exceeds net income of €33.97 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of SCHOTT Pharma AG & Co. KGaA to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of SCHOTT Pharma AG & Co. KGaA (2020–2024)
Cash flow quality index of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. Historical Cash Flow Quality Index for SCHOTT Pharma AG & Co. KGaA across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 1SXP net asset quality score to measure how much of total assets are equity-financed.
SCHOTT Pharma AG & Co. KGaA Cash Flow Quality Index by Year (2020–2024)
SCHOTT Pharma AG & Co. KGaA cash flow quality index by year from 2020 to 2024. Year-by-year earnings quality comparison for SCHOTT Pharma AG & Co. KGaA. For the full cash flow conversion analysis, see SCHOTT Pharma AG & Co. KGaA cash flow conversion.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.51x | €225.33 Million | €149.69 Million | ▲ +25.8% |
| 2023 | 1.20x | €181.65 Million | €151.84 Million | ▼ -17.6% |
| 2022 | 1.45x | €182.12 Million | €125.38 Million | ▲ +10.7% |
| 2021 | 1.31x | €132.21 Million | €100.75 Million | ▼ -2.6% |
| 2020 | 1.35x | €104.40 Million | €77.48 Million | — |